Rationale and recommendations for treatment of radiation injury with cytokines

Health Physics

Volumn 98, Issue 6, 2010, Pages 838-842

  Dainiak, Nicholas ^a,b  

^a BRIDGEPORT HOSPITAL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Accidents; Bone marrow; Nuclear; Radiation damage; World Health Organization

Indexed keywords

CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; LIGAND;

AGED; ANIMAL; CELL LINEAGE; CHILD; CONFERENCE PAPER; CYTOLOGY; DOG; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; METHODOLOGY; NUCLEAR ACCIDENT; PRIMATE; RADIATION INJURY; STEM CELL;

AGED; ANIMALS; CELL LINEAGE; CHILD; CYTOKINES; DOGS; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; LIGANDS; PRIMATES; RADIATION INJURIES; RADIOACTIVE HAZARD RELEASE; STEM CELLS;

PRIMATES;

EID: 77951995812     PISSN: 00179078     EISSN: None     Source Type: Journal    
DOI: 10.1097/HP.0b013e3181b3fce5     Document Type: Conference Paper

References (28)

1. American Society of Clinical Oncology. Recommendations for use of hematopoietic colony-stimulating factors: evidencebased, clinical practice guidelines. J Clin Oncol 12:2471-2508; 1994.
2. Asano S. Multi-organ involvement: lessons from the experience of one victim of the Tokai-mura criticality accident. Brit J Radiol Suppl 27:9-12; 2005.
3. Baranov AE, Guskova AK, Nadejina NM, Nugis VY. Chernobyl experiences: biological indications of exposure to ionizing radiation. Stem Cells 13(Suppl 1):69-77; 1995.
4. Begley CG, Lopez AF, Nicola NA, Warrend DJ, Vadas MS, Sanderson CJ, Metcalf D. Purified colony-stimulating factors enhance the survival of human neutrophils and eosinophils in vitro: a rapid and sensitive microassay for colony-stimulating factors. Blood 68:162-166; 1986.
5. Blakely WF, Ossetrova NI, Manglapus GL, Salter CA, Levine IH, Jackson WE, Grace MB, Prasanna PGS, Sandgren DJ, Ledney GD. Amylase and blood cell-count hematological radiation-injury biomarkers in a rhesus monkey radiation model-use of multiparameter and integrated biological dosimetry. Radiat Meas 42:1164-1170; 2007.
6. Dainiak N. Hematologic consequences of exposure to ionizing radiation. Exp Hematol 30:513-528; 2002.
7. Dainiak N, Waselenko JK, Armitage JO, MacVittie TJ, Farese AM. The hematologist and radiation casualties. Hematol (Am Soc Hematol Educ Program): 473; 2003.
8. Dainiak N, Berger P, Albanese J. Relevance and feasibility of multi-parameter assessment of mass casualties from a radiological event. Exp Hematol 35(Suppl 1):17-23; 2007.
9. Drouet M, Mourein F, Grenier N, Leroux V, Denis J, Mayol JF, Thullier P, Lataillade JJ, Herodin F. Single administration of stem cell factor, FLT-3 ligand, megakaryocyte growth and development factor and interleukin-3 in combination soon after irradiation prevents non human primates from myelosuppression: long-term follow-up of hematopoiesis. Blood 103:878-885; 2004.
10. Fliedner TM, Friesecke I, Beyrer K. Medical management of radiation accidents: manual on the acute radiation syndrome. Oxford: British Inst Radiology; 2001.
11. Fliedner TM, Graessle D, Meineke V, Door H. Pathophysiological principles underlying the blood cells concentration responses used to assess the severity of effect after accidental whole-body radiation exposure: an essential basis for an evidence-based clinical triage. Exp Hematol 35(Suppl 1):8-16; 2007.
12. Goans RE, Holloway EC, Berger ME, Ricks RC. Early dose assessment following severe radiation accidents. Health Phys 72:513-518; 1997.
13. Gorin N-C, Fliedner TM, Gourmelon P, Gauser A, Meineke V, Sirhoi B, Powles R, Apperley J. Consensus conference on European preparedness for haematological and other medical management of mass radiation accident. Ann Hematol 85:671-679; 2006.
14. Greil R, Psenak O, Rolia F. Hematopoietic growth factors: ESMO recommendations for the applications. Ann Oncol 19(Suppl 2):116-118; 2008.
15. Herodin F, Bourin P, Mayol JF, Latallade JJ, Drouet M. Short-term injection of antiopoptotic cytokine combinations seen after lethal gamma irradiation promotes survival. Blood 101:2609-2616; 2003.
16. Herodin F, Grenier N, Drouet M. Revisiting therapeutic strategies in radiation casualties. Exp Hematol 35:28-33; 2007.
17. Inoue T, Hirabayashi Y, Mitsui H, Sasaki H, Cronkite EP, Bullis JE Jr, Bond VP, Yoshida K. Survival of spleen colony-forming units (CFU-S) of irradiated bone marrow cells in mice: evidence for the existence of a radioresistant subfraction. Exp Hematol 23:1296-1300; 1995.
18. Jordan JD, Landau EM, Iyengar R. Signaling networks: the origins of cellular multitasking. Cell 103:193-200; 2000.
19. Kuter DJ. New thrombopoietic growth factors. Blood 109:4607-4616; 2007.
20. MacVittie TJ, Monroy R, Vigneulle RM. The relative biological effectiveness of mixed fission-neutron-gamma radiation on the hematopoietic syndrome in the canine: effect of therapy on survival. Radiat Res 128:S29; 1991.
21. Maekawa K. Overview of medical care for highly exposed victims in the Tokaimura accident. In: Ricks RC, Berger ME, O'Hara FM, eds. The medical basis for radiation accident preparedness. The clinical care of victims. New York: Parthenon; 2002: 313-318.
22. McCulloch EA, Till JE. The sensitivity of cells from normal mouse bone marrow to radiation in vitro and in vivo. Radiat Res 16:822-830; 1962.
23. Neelis KJ, Dubbelman YD, Qingliang L, Thomas GR, Eaton DL, Wagemaker G. Simultaneous administration of TPO and G-CSF after cytoreductive treatment of rhesus monkeys prevents thrombocytopenia, accelerates platelet and red cell reconstitution, alleviates neutropenia, and promotes the recovery of immature bone marrow cells. Exp Hematol 25:1084-1093; 1997.
24. Pawson T. Specificity in signal transduction: from phosphotyrosine-SH2 domain interactions to complex cellular systems. Cell 116:191-203; 2004.
25. Santini V, Scappini B, Indik ZK, Gozzini A, Ferrine R, Schreiber AD. The carboxy-terminal region of the granulocyte colony-stimulating factor receptor transduces a phagocytic signal. Blood 101:4615; 2003.
26. Smith TJ, Khatcheressian J, Lyman GH. 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline. J Clin Oncol 24:3187-3205; 2006.
27. Waselenko JK, MacVittie TJ, Blakely WF, Pesik N, Wiley AL, Dickerson WE, Tsu H, Confer DL, Coleman CN, Seed T, Lowry P, Armitage JO, Dainiak N. Medical management of the acute radiation syndrome: recommendations of the Strategic National Stockpile Radiation Working Group. Ann Intern Med 140:1037-1051; 2004.
28. Wingard JR, Dainiak N. Treatment of radiation injury in the adult. Up-to-Date, Version 17.2. Available at: http://www. uptodate.com. Accessed 25 March 2010.